HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LFSC

F/m Emerald Life Sciences Innovation ETF

Last Close
Sep 12  •  04:00PM ET
28.04
Dollar change
-0.81
Percentage change
-2.82 %
Financial • Exchange Traded Fund • USA • NASD
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings36 Perf Week-3.12%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM66.07M Perf Month8.43%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter22.81%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High29.30 -4.31% Perf Half Y12.96%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 49.29% Perf YTD19.86%
Active/Passive Quant Type Tagsmedical Flows% 1M2.17% Volatility0.85% 1.22% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M4.97% ATR (14)0.44 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD11.65% RSI (14)57.10 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.54% Growth/Value SMA200.25% Flows% 3Y Rel Volume0.09 Prev Close28.85
Inverse/Leveraged Market Cap SMA507.41% Flows% 5Y Avg Volume3.32K Price28.04
IPOOct 31, 2024 Option/ShortNo / Yes SMA20014.32% Trades Volume285 Change-2.82%
Feb-04-25 10:15AM
Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference
(Business Wire)
Oct-31-24 07:30AM
Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC)
(Business Wire)
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
open in yahoo | open in marketwatch | open in google
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.